Langzhi Group Double Pharmaceutical

Langzhi Group is a prominent Chinese pharmaceutical company headquartered in Beijing, specializing in the development, manufacturing, and distribution of high-quality medicines. The company's portfolio is particularly strong in cardiovascular and cerebrovascular health, respiratory treatments, and anti-infective therapies, featuring both chemical drugs and standardized traditional Chinese medicine extracts. Through its key subsidiary, Shanxi Langzhi Double-Crane Pharmaceutical, the group operates large-scale, GMP-certified production facilities that supply essential medications to the Chinese domestic market. Langzhi Group is recognized for its integration of research and development with robust commercial operations, maintaining a significant presence in the hospital and retail pharmacy sectors. The company continues to expand its pipeline through internal innovation and strategic acquisitions within the Chinese healthcare landscape.